黄芪甲苷通过抑制PKC/MAPK通路修复损伤人足细胞裂孔膜
Astragaloside Ⅳ Repairs the Damage of Human Podocyte Slit Diaphragm by Restraining PKC/MAPK Pathway
-
摘要: 探讨核苷酸嘌呤霉素对人足细胞的损伤作用及黄芪甲苷的修复作用,并探索PKC/MAPK通路是否参与其中,寻找可能存在的作用机制。方法 用CCK-8法筛选合适的核苷酸嘌呤霉素造模浓度及黄芪甲苷的最大无毒浓度,予核苷酸嘌呤霉素刺激人足细胞造成损伤,予不同浓度的黄芪甲苷处理后,应用Western blot法检测nephrin、podocin、PKC、JNK及p38蛋白水平的表达情况。结果 核苷酸嘌呤霉素刺激后,nephrin、podocin的蛋白的表达明显降低,而PKC、JNK、p38的表达明显上升,用药后渐趋正常,且呈浓度依赖性,差异有统计学意义(P<0.05),溶剂对照组无明显改变,无统计学差异(P>0.05)。结论 核苷酸嘌呤霉素能造成人足细胞裂孔膜损伤,黄芪甲苷对这种损伤有修复作用,而PKC/MAPK通路参与修复过程,同时这种修复作用与黄芪甲苷浓度呈正相关。Abstract: OBJECTIVE To investigate the damage effects of puromycin aminonucleoside (PAN) on human podocyte and the repair effect of astragaloside Ⅳ. At the same time,to explore whether PKC/MAPK pathway is involved in it to seek possible mechanisms. METHODS To filter appropriate concentration of model establishment of PAN and the maximum non-toxic concentration of astragaloside Ⅳ by cytotoxicity test CCK-8.In the experiment,PAN was used to cause the damage of human podocytes and then different concentrations of astragaloside Ⅳ was treated with cells.Finally,the protein expression levels of nephrin, podocin, PKC, JNK and p38 were detected by Western blotting. RESULTS The protein expression levels of nephrin and podocin were declined as where as PKC, JNK and p38 were ascended obviously after stimulating by PAN and tended to nomal gradually after treatment with astragaloside Ⅳ,furthermore,these changes were in a dose-dependent manner.The difference was statistically significant (P<0.05).However,the changes between solvent control group and model group were unconspicuous, which showed no significant difference. CONCLUSION PAN can cause the damage of human podocyte slit diaphragm and astragaloside Ⅳ can repair the injury which is positively correlated with astragaloside Ⅳ. Meanwhile, PKC/MAPK pathway is involved in the repair process.This may be the possible mechanism of Astragaloside Ⅳ on the repair of human podocyte.